Regeneron and Alnylam announce $1bn collaborationRegeneron has signed a collaboration deal potentially worth $1 billion with RNAi experts Alnylam Pharmaceuticals, to develop and Share XRegeneron and Alnylam announce $1bn collaborationhttps://pharmaphorum.com/news/regeneron-and-alnylam-announce-1bn-collaboration/
